Sign in

CIK 0001517022

  • Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208756903
Phone
+1 617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-08-06 Butler John P. CEO and President Exercise or conversion +350,000 $0.63 $221K 3,718,564
2026-08-06 Butler John P. CEO and President Exercise or conversion · Stock Option (Right to buy) −350,000 525,000
2026-03-04 Butler John P. CEO and President Purchase +69,270 $1.25 $87K 3,367,064
2026-02-02 Butler John P. CEO and President Sale 10b5-1 −46,660 $1.39 $65K 3,417,189
2026-02-02 Butler John P. CEO and President Sale 10b5-1 −96,065 $1.39 $134K 3,321,124
2026-02-02 Butler John P. CEO and President Sale 10b5-1 −114,891 $1.39 $160K 3,206,233
2026-02-02 Butler John P. CEO and President Grant or award 10b5-1 +175,250 $1.41 $247K 3,381,483
2026-02-02 Butler John P. CEO and President Sale 10b5-1 −83,689 $1.39 $116K 3,297,794
2026-01-30 Butler John P. CEO and President Grant or award +743,000 3,463,849
2026-01-30 Butler John P. CEO and President Grant or award · Stock Option (Right to buy) +1,115,000 1,115,000
2025-03-03 Butler John P. CEO and President Sale 10b5-1 −46,409 $1.83 $85K 2,557,921
2025-02-03 Butler John P. CEO and President Sale 10b5-1 −46,268 $2.10 $97K 2,702,312
2025-02-03 Butler John P. CEO and President Sale 10b5-1 −97,982 $2.10 $206K 2,604,330
2025-01-31 Butler John P. CEO and President Grant or award 10b5-1 +701,000 2,748,580
2025-01-31 Butler John P. CEO and President Grant or award · Performance Stock Units 10b5-1 +350,500 350,500
2025-01-31 Butler John P. CEO and President Grant or award · Stock Option (Right to buy) 10b5-1 +1,051,400 1,051,400
2024-02-29 Butler John P. CEO and President Sale −46,570 $1.58 $74K 2,044,580
2024-02-27 Butler John P. CEO and President Sale −37,733 $1.52 $57K 2,091,150
2024-02-01 Butler John P. CEO and President Sale −46,489 $1.68 $78K 2,128,883
2024-01-31 Butler John P. CEO and President Grant or award +603,500 2,175,372

Page 1 of 4 · 74 trades